Search research articles
Contact Us
Filters
Showing results (1-10 of 352) with videos related to
Page
of 36
Sort By:
Journal of Cardiovascular Pharmacology and Therapeutics
|
May 3, 2019
Reply to Letter to the Editor-Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction
Dae Ho Lee
ESMO Open
|
June 27, 2018
Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era
Dae Ho Lee
Diabetes & Metabolism Journal
|
August 25, 2015
Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
Dae Ho Lee
The Journal of Clinical Endocrinology and Metabolism
|
December 8, 2022
Response to Letter to the Editor From Han and Xu: "Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes"
Dae Ho Lee
Diabetes & Metabolism Journal
|
September 13, 2014
Lipoproteins and β-Cell Functions: From Basic to Clinical Data
Dae Ho Lee
Endocrinology and Metabolism (Seoul, Korea)
|
July 4, 2020
Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
Dae Ho Lee
Journal of Thoracic Disease
|
August 9, 2016
Second-generation anaplastic lymphoma kinase inhibitors: revolutionary or evolutionary?
Dae Ho Lee
BMB Reports
|
January 7, 2021
Update of early phase clinical trials in cancer immunotherapy
Dae Ho Lee
Cancer Research and Treatment
|
October 16, 2022
Treating Oligometastses, Prelude or Just Hassles of Systemic Treatment
Dae Ho Lee
Pharmacology & Therapeutics
|
February 8, 2017
Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures
Dae Ho Lee
Page
of 36
Search research articles
Search
Showing results (1-10 of 352) with videos related to
Sort By:
Page
of 36
Journal of Cardiovascular Pharmacology and Therapeutics
|
May 3, 2019
Reply to Letter to the Editor-Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Myocardial Infarction
Dae Ho Lee
ESMO Open
|
June 27, 2018
Practical issues of biomarker-assisted targeted therapy in precision medicine and immuno-oncology era
Dae Ho Lee
Diabetes & Metabolism Journal
|
August 25, 2015
Letter: Increased Risk of Hospitalization for Heart Failure with Newly Prescribed Dipeptidyl Peptidase-4 Inhibitors and Pioglitazone Using the Korean Health Insurance Claims Database (Diabetes Metab J 2015;39:247-52)
Dae Ho Lee
The Journal of Clinical Endocrinology and Metabolism
|
December 8, 2022
Response to Letter to the Editor From Han and Xu: "Association Between DPP4 Inhibitor Use and the Incidence of Cirrhosis, ESRD, and Some Cancers in Patients With Diabetes"
Dae Ho Lee
Diabetes & Metabolism Journal
|
September 13, 2014
Lipoproteins and β-Cell Functions: From Basic to Clinical Data
Dae Ho Lee
Endocrinology and Metabolism (Seoul, Korea)
|
July 4, 2020
Noninvasive Evaluation of Nonalcoholic Fatty Liver Disease
Dae Ho Lee
Journal of Thoracic Disease
|
August 9, 2016
Second-generation anaplastic lymphoma kinase inhibitors: revolutionary or evolutionary?
Dae Ho Lee
BMB Reports
|
January 7, 2021
Update of early phase clinical trials in cancer immunotherapy
Dae Ho Lee
Cancer Research and Treatment
|
October 16, 2022
Treating Oligometastses, Prelude or Just Hassles of Systemic Treatment
Dae Ho Lee
Pharmacology & Therapeutics
|
February 8, 2017
Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): The road to a success, paved with failures
Dae Ho Lee
Page
of 36